|
Title
|
FOA/Notice Number
|
Related |
Issuing Org
|
Released ▼
|
Opens
|
Expires
|
Activity Code
|
| Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States Including in Health Disparities Populations (U19 Clinical Trial not Allowed) |
RFA-NS-19-012 |
Related |
NINDS
| 02-15-2019 |
03-17-2019 |
04-18-2019 |
U19 |
| Enhancing Regulatory Science for the Risk Based Quality Assessment of Complex Products (U01) - Clinical Trials Optional |
RFA-FD-19-011 |
Related |
FDA
| 02-13-2019 |
02-19-2019 |
04-23-2019 |
U01 |
| Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U19 Clinical Trial Optional) |
RFA-FD-19-003 |
Related |
FDA
| 02-12-2019 |
02-19-2019 |
04-22-2019 |
U19 |
| Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed) |
RFA-ES-19-001 |
Related |
NIEHS
| 02-08-2019 |
04-16-2019 |
05-17-2019 |
R01 |
| Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed) |
RFA-ES-19-002 |
Related |
NIEHS
| 02-08-2019 |
04-16-2019 |
05-17-2019 |
R21 |
| Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) |
RFA-AI-19-012 |
Related |
NIAID
| 02-08-2019 |
04-30-2019 |
06-01-2019 |
U19 |
| Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed) |
RFA-ES-19-005 |
Related |
NIEHS
| 02-08-2019 |
03-09-2019 |
04-10-2019 |
R43/R44 |
| Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed) |
RFA-ES-19-006 |
Related |
NIEHS
| 02-08-2019 |
03-09-2019 |
04-10-2019 |
R41/R42 |
| Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed) |
RFA-NS-19-022 |
Related |
NINDS
| 02-07-2019 |
03-10-2019 |
04-11-2019 |
U54 |
| Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed) |
RFA-FD-19-010 |
Related |
FDA
| 02-07-2019 |
02-11-2019 |
04-12-2019 |
U01 |
| Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations (U01 Clinical Trial Required) |
RFA-FD-19-009 |
Related |
FDA
| 02-07-2019 |
02-11-2019 |
04-12-2019 |
U01 |
| Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed) |
RFA-FD-19-008 |
Related |
FDA
| 02-07-2019 |
02-11-2019 |
04-12-2019 |
U01 |
| Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required) |
RFA-FD-19-014 |
Related |
FDA
| 02-06-2019 |
02-06-2019 |
04-05-2019 |
U01 |
| Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) |
RFA-MH-20-110 |
Related |
NIMH
| 02-06-2019 |
04-02-2019 |
01-03-2020 |
R01 |
| Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
RFA-OD-19-016 |
Related |
NIH
| 02-05-2019 |
02-14-2018 |
03-15-2019 |
R01 |
| Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trials Required) |
RFA-OD-19-018 |
Related |
NIH
| 02-05-2019 |
02-14-2019 |
03-15-2019 |
R61/R33 |
| INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
RFA-OD-19-015 |
Related |
NIH
| 02-05-2019 |
02-14-2019 |
03-15-2019 |
R21 |
| Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and Developmental Transitions (R34 Clinical Trial Required) |
RFA-MH-20-100 |
Related |
NIMH
| 02-04-2019 |
04-01-2019 |
11-16-2019 |
R34 |
| NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed) |
RFA-CA-19-010 |
Related |
NCI
| 02-01-2019 |
03-01-2019 |
04-02-2019 |
UE5 |
| NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-CA-19-011 |
Related |
NCI
| 02-01-2019 |
03-01-2019 |
04-02-2019 |
U24 |
| George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional) |
RFA-DK-18-029 |
Related |
NIDDK
| 01-31-2019 |
03-24-2019 |
04-25-2019 |
U54 |
| Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional) |
RFA-DK-18-027 |
Related |
NIDDK
| 01-31-2019 |
03-24-2019 |
04-25-2019 |
K12 |
| Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18) |
RFA-HS-19-001 |
Related |
AHRQ
| 01-31-2019 |
01-31-2019 |
04-01-2019 |
R18 |
| Computational Models of Immunity (U01 Clinical Trial Not Allowed) |
RFA-AI-19-011 |
Related |
NIAID
| 01-30-2019 |
05-10-2019 |
06-11-2019 |
U01 |
| High Quality Human Reference Genomes (HQRG) (U01 Clinical Trial Not Allowed) |
RFA-HG-19-002 |
Related |
NHGRI
| 01-30-2019 |
03-02-2019 |
04-03-2019 |
U01 |
| Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed) |
RFA-HG-19-004 |
Related |
NHGRI
| 01-30-2019 |
03-02-2019 |
04-03-2019 |
U41 |
| Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed) |
RFA-HG-19-003 |
Related |
NHGRI
| 01-30-2019 |
03-02-2019 |
04-03-2019 |
U01 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional) |
RFA-MH-20-202 |
Related |
NIMH
| 01-29-2019 |
03-10-2019 |
04-11-2019 |
R34 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional) |
RFA-MH-20-201 |
Related |
NIMH
| 01-29-2019 |
03-10-2019 |
04-11-2019 |
R21 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional) |
RFA-MH-20-200 |
Related |
NIMH
| 01-29-2019 |
03-10-2019 |
04-11-2019 |
R01 |
| Developmental Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Not Allowed) |
RFA-DK-18-028 |
Related |
NIDDK
| 01-29-2019 |
03-10-2019 |
04-11-2019 |
P20 |
| Human Three-Dimensional Cell Model Systems for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) |
RFA-NS-19-027 |
Related |
NINDS
| 01-29-2019 |
02-14-2019 |
03-15-2019 |
UG3/UH3 |
| Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed) |
RFA-FD-19-002 |
Related |
FDA
| 01-29-2019 |
02-04-2019 |
04-05-2019 |
U01 |
| Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (U01 Clinical Trial Required) |
RFA-DK-18-025 |
Related |
NIDDK
| 01-28-2019 |
03-10-2019 |
04-11-2019 |
U01 |
| Data Coordinating Center for the Advanced Clinical Trials Consortium to Test Artificial Pancreas Device Systems (U24 Clinical Trial Not Allowed) |
RFA-DK-18-026 |
Related |
NIDDK
| 01-28-2019 |
03-10-2019 |
04-11-2019 |
U24 |
| The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) |
RFA-DK-18-024 |
Related |
NIDDK
| 01-28-2019 |
03-10-2019 |
11-21-2019 |
F99/K00 |
| Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed) |
RFA-MH-20-210 |
Related |
NIMH
| 01-25-2019 |
05-24-2019 |
06-25-2019 |
R24 |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) |
RFA-HL-20-012 |
Related |
NHLBI
| 01-25-2019 |
02-14-2019 |
04-16-2021 |
R35 |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) |
RFA-HL-20-011 |
Related |
NHLBI
| 01-25-2019 |
02-14-2019 |
04-16-2021 |
R35 |
| Mechanistic studies on chronic alcohol use and sleep homeostasis (R01 Clinical Trial Optional) |
RFA-AA-19-006 |
Related |
NIAAA
| 01-24-2019 |
03-17-2019 |
04-18-2019 |
R01 |
| Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) |
RFA-CA-19-032 |
Related |
NCI
| 01-24-2019 |
07-01-2019 |
08-04-2020 |
R01 |
| HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) |
RFA-AI-19-006 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required) |
RFA-AI-19-001 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) |
RFA-AI-19-005 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) |
RFA-AI-19-004 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) |
RFA-AI-19-003 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required) |
RFA-AI-19-002 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed) |
RFA-DK-19-001 |
Related |
NIDDK
| 01-23-2019 |
03-17-2019 |
04-18-2019 |
U01 |
| Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed) |
RFA-DK-18-007 |
Related |
NIDDK
| 01-23-2019 |
03-11-2019 |
04-12-2019 |
U34 |
| Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) (U41 Clinical Trial Not Allowed) |
RFA-AT-19-003 |
Related |
NCCIH
(formerly NCCAM)
| 01-22-2019 |
03-29-2019 |
04-30-2019 |
U41 |
| Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional) |
RFA-OD-19-001 |
Related |
ODS
| 01-22-2019 |
03-15-2019 |
04-16-2019 |
U19 |
| Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed) |
RFA-AT-19-002 |
Related |
NCCIH
(formerly NCCAM)
| 01-22-2019 |
03-01-2019 |
04-02-2019 |
U24 |
| Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) |
RFA-MD-19-001 |
Related |
NIMHD
| 01-18-2019 |
03-01-2019 |
04-02-2019 |
R43/R44 |
| Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed) |
RFA-DK-18-023 |
Related |
NIDDK
| 01-18-2019 |
02-21-2019 |
03-22-2019 |
R43/R44 |
| Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed) |
RFA-HD-19-024 |
Related |
NICHD
| 01-16-2019 |
03-04-2019 |
05-15-2019 |
R01 |
| Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 - Clinical Trial Optional) |
RFA-DA-19-033 |
Related |
NIDA
| 01-11-2019 |
02-20-2019 |
03-21-2019 |
R43/R44 |
| Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 - Clinical Trial Optional) |
RFA-DA-19-032 |
Related |
NIDA
| 01-11-2019 |
02-20-2019 |
03-21-2019 |
R41/R42 |
| Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) |
RFA-CA-19-033 |
Related |
NCI
| 01-11-2019 |
02-15-2019 |
01-04-2020 |
U01 |
| Limited Competition for the Continuation of the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) |
RFA-DK-18-509 |
Related |
NIDDK
| 01-10-2019 |
02-21-2019 |
03-22-2019 |
U01 |
| Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed) |
RFA-DK-18-008 |
Related |
NIDDK
| 01-10-2019 |
02-21-2019 |
03-22-2019 |
U01 |
| The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required) |
RFA-CA-19-007 |
Related |
NCI
| 01-10-2019 |
04-22-2019 |
05-23-2019 |
UM1 |
| The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trials Not Allowed) |
RFA-CA-19-008 |
Related |
NCI
| 01-10-2019 |
04-22-2019 |
05-23-2019 |
U24 |
| Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R41/R42 Clinical Trial Optional) |
RFA-DA-19-022 |
Related |
NIDA
| 01-09-2019 |
02-19-2019 |
03-20-2019 |
R41/R42 |
| Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R43/R44 Clinical Trial Optional) |
RFA-DA-19-021 |
Related |
NIDA
| 01-09-2019 |
02-19-2019 |
03-20-2019 |
R43/R44 |
| The Human Biomolecular Atlas Program (HuBMAP): Rapid Implementation of Technologies that Will Accelerate Development of a Framework for Mapping the Human Body at High Resolution (UH3 Clinical Trial Not Allowed) |
RFA-RM-19-002 |
Related |
RMOD
| 01-09-2019 |
02-14-2019 |
03-15-2019 |
UH3 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
RFA-CA-19-026 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
P01 |
| Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
RFA-CA-19-024 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
U01 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
RFA-CA-19-023 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R01 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
RFA-CA-19-027 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
P50 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) |
RFA-CA-19-025 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
U54 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
RFA-CA-19-028 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
U2C |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) |
RFA-CA-19-021 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R21 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) |
RFA-CA-19-020 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R33 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) |
RFA-CA-19-019 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R21 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) |
RFA-CA-19-022 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R33 |
| Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional) |
RFA-AT-19-009 |
Related |
NCCIH
(formerly NCCAM)
| 01-03-2019 |
02-15-2019 |
03-16-2019 |
R21 |
| Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional) |
RFA-AT-19-008 |
Related |
NCCIH
(formerly NCCAM)
| 01-03-2019 |
02-15-2019 |
03-16-2019 |
R01 |
| U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional) |
RFA-CA-19-009 |
Related |
NCI
| 01-02-2019 |
01-21-2019 |
02-22-2019 |
R01 |
| Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed) |
RFA-DA-19-030 |
Related |
NIDA
| 01-02-2019 |
02-04-2019 |
03-05-2019 |
R41/R42 |
| Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed) |
RFA-DA-19-031 |
Related |
NIDA
| 01-02-2019 |
02-04-2019 |
03-05-2019 |
R43/R44 |
| Resources for Technology Dissemination (U24 Clinical Trial Not Allowed) |
RFA-EB-18-002 |
Related |
NIBIB
| 12-26-2018 |
01-27-2019 |
02-28-2019 |
U24 |
| HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34- Clinical Trial Not Allowed) |
RFA-DA-19-029 |
Related |
NIDA
| 12-21-2018 |
02-25-2019 |
03-26-2019 |
R34 |
| HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) ( R34- Clinical Trial Not Allowed) |
RFA-DA-19-036 |
Related |
NIDA
| 12-21-2018 |
02-25-2019 |
03-26-2019 |
R34 |
| Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders (UG1 Clinical Trial Required) |
RFA-DA-19-018 |
Related |
NIDA
| 12-21-2018 |
02-15-2019 |
03-16-2019 |
UG1 |
| NEI Audacious Goals Initiative: Preliminary Studies for Translation-Enabling Models of the Visual System (R21 Clinical Trial Not Allowed) |
RFA-EY-19-001 |
Related |
NEI
| 12-20-2018 |
02-08-2019 |
03-09-2019 |
R21 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) |
RFA-CA-19-029 |
Related |
NCI
| 12-20-2018 |
01-26-2019 |
02-27-2019 |
K99/R00 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) |
RFA-CA-19-030 |
Related |
NCI
| 12-20-2018 |
01-26-2019 |
02-27-2019 |
K99/R00 |
| Revision Application for Implementation Research to Inform and Enhance PEPFAR HIV Pre-exposure Prophylaxis (PrEP) Delivery (R01 Clinical Trial Optional) |
RFA-MH-19-425 |
Related |
NIMH
| 12-19-2018 |
01-18-2019 |
02-20-2019 |
R01 |
| Limited Competition: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed) |
RFA-EB-18-004 |
Related |
NIBIB
| 12-18-2018 |
01-22-2019 |
02-23-2019 |
R24 |
| NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed) |
RFA-OD-19-014 |
Related |
NIH
| 12-17-2018 |
02-19-2019 |
03-20-2019 |
U01 |
| Human Islet Research Network - Consortium on Modeling Autoimmune Interactions (HIRN-CMAI) (U01 Clinical Trial Not Allowed) |
RFA-DK-18-013 |
Related |
NIDDK
| 12-17-2018 |
01-26-2019 |
02-27-2019 |
U01 |
| NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trials Not Allowed) |
RFA-DE-19-007 |
Related |
NIDCR
| 12-12-2018 |
04-30-2019 |
05-31-2019 |
UE5 |
| Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) |
RFA-AA-19-003 |
Related |
NIAAA
| 12-11-2018 |
03-16-2019 |
04-17-2019 |
P60 |
| HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required) |
RFA-DA-19-035 |
Related |
NIDA
| 12-10-2018 |
02-13-2019 |
03-14-2019 |
UG3/UH3 |
| HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed) |
RFA-TR-19-005 |
Related |
NCATS
| 12-10-2018 |
01-28-2019 |
03-01-2019 |
UH2/UH3 |
| HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed) |
RFA-TR-19-003 |
Related |
NCATS
| 12-10-2018 |
01-28-2019 |
03-01-2019 |
UG3/UH3 |
| HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed) |
RFA-NS-19-020 |
Related |
NINDS
| 12-10-2018 |
12-09-2018 |
03-07-2019 |
U44 |
| HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required) |
RFA-MH-19-525 |
Related |
NIMH
| 12-10-2018 |
03-01-2019 |
04-02-2019 |
U01 |
| HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3 Clinical Trial Optional) |
RFA-AR-19-028 |
Related |
NIAMS
| 12-10-2018 |
02-20-2019 |
03-21-2019 |
UH2/UH3 |
| HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) |
RFA-NS-19-016 |
Related |
NINDS
| 12-10-2018 |
12-09-2018 |
02-23-2021 |
UG3/UH3 |
NIH Staff